Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Birth size and early pneumonia predict linear growth among HIV‐exposed uninfected infants

Domaine:

healthcare

Type de record:

paper
Créateur:
EmiPatBarDor
Éditeur:
WILEY
Hôte:
Abstract Stunting remains a global health priority, particularly in sub‐Saharan Africa. Identifying determinants of linear growth in HIV‐exposed uninfected (HEU) infants can inform interventions to prevent stunting in this vulnerable population. HIV‐infected mothers and their uninfected infants were followed monthly from pregnancy to 12‐month post‐partum in Nairobi, Kenya. Mixed‐effects models estimated the change in length‐for‐age z‐score (LAZ) from birth to 12 months by environmental, maternal, and infant characteristics. Multivariable models included factors univariately associated with LAZ. Among 372 HEU infants, mean LAZ decreased from −0.54 (95% confidence interval [CI] [−0.67, −0.41]) to −1.09 (95% CI [−1.23, −0.96]) between 0 and 12 months. Declines in LAZ were associated with crowding (≥2 persons per room; adjusted difference [AD] in 0–12 month change: −0.46; 95% CI [−0.87, −0.05]), use of a pit latrine versus a flush toilet (AD: −0.29; 95% CI [−0.57, −0.02]), and early infant pneumonia (AD: −1.14; 95% CI [−1.99, −0.29]). Infants with low birthweight (<2,500 g; AD: 1.08; 95% CI [0.40, 1.76]) and birth stunting (AD: 1.11; 95% CI [0.45, 1.78]) experienced improved linear growth. By 12 months of age, 46 infants were stunted, of whom 11 (24%) were stunted at birth. Of the 34 infants stunted at birth with an available 12‐month LAZ, 68% were not stunted at 12 months. Some low birthweight and birth‐stunted HEU infants had significant linear growth recovery. Early infant pneumonia and household environment predicted poor linear growth and may identify a subgroup of HEU infants for whom to provide growth‐promoting interventions.

Visit

doi.org

Licenses

http://onlinelibrary.wiley.com/termsAndConditions#vor

Similaires

Growth faltering and developmental delay in HIV-exposed uninfected infantsPlacental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected InfantsHigher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in KenyaIncreased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposedCompromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in NigeriaInfectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants

Growth faltering and developmental delay in HIV-exposed uninfected infants

Background Human Immunodeficiency Virus (HIV) is a major cause of mortality and morbidity globally.

Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants

Abstract Background Maternal human immunode

Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya

Background: With the growing population of HIV-exposed uninfected (HEU) children globa

Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed

Objectives: Increased risk of morbidity and hospitalization has been observed in child

Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria

Background: HIV-exposed but uninfected (HEU) children may be at an increased risk of i

Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants

Background: HIV-exposed uninfected (HEU) infants are a growing population with potenti